Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Drug interactions and side effects of Tirzepatide Regulatory Approvals/Commercial Developed by Eli Lilly and approved by the US FDA in 2022, Mounjaro (Tirzepatide) is prescribed as a subcutaneous pen-injector
In rabbits, but not in rats, there was a statistically non-significantly higher number of post-implantation losses at the highest dose tested (600 mg/kg per day) compared to the control group
Presented for research literature review only Maggio M et al
J Int Neuropsychol Soc
Math assumes 10 mg vials reconstituted with 2 mL BAC water unless otherwise noted
US$ 25.99
US$ 24.47
US$ 25.64
US$ 24.93
US$ 29.49
US$ 24.25
US$ 29.83
